RENE Share PerformanceMore
|52 week high||6.5000 15/07/15|
|52 week low||2.8000 22/01/15|
|52 week change||-1.0000 (-25.81%)|
|4 week volume||46,086,364 01/11/15|
Media for (RENE)
Latest News« previous» nextMore
12/11/2015 - 14:51 StockMarketWire
ReNeuron Group has confirmed that it will announce its interim results for the six months ended 30 September 2015 on M...
12/11/2015 - 14:45 RNS
RNS Number: 5422F ReNeuron Group plc 12 November 2015 12 November 2015 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Notification of Interim Results Guildford, UK, 12 November 2015: ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy company, will announce its interim results for the six months ended 30 Sept...
06/11/2015 - 15:29 RNS
RNS Number: 9159E ReNeuron Group plc 06 November 2015 6 November 2015 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Total Voting Rights In conformity with the FCA's Disclosure and Transparency Rules, ReNeuron Group plc confirms that, as at the close of business on 30 October 2015, the Company had 3,159,256,868 ordinary shares of...
02/10/2015 - 14:01 RNS
RNS Number: 1172B ReNeuron Group plc 02 October 2015 2 October 2015 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Directors' Interest in Shares and Share Options Guildford, UK, 2 October 2015: ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy company, today announces that on 1 October 2015 , the following award...
28/09/2015 - 11:18 RNS
RNS Number: 3995A ReNeuron Group plc 28 September 2015 28 September 2015 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Block Admission and Total Voting Rights Guildford, UK, 28 September 2015: ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy company, today announces that an application has been made to ...
24/09/2015 - 13:03 StockMarketWire
ReNeuron Group has announced that all resolutions put to shareholders at today's Annual General Meeting were duly pass...
24/09/2015 - 12:50 RNS
RNS Number: 1335A ReNeuron Group plc 24 September 2015 24 September 2015 AIM: RENE ReNeuron Group plc Result of AGM Guildford, UK, 24 September 2015: ReNeuron Group plc (the "Company") (AIM: RENE), a leading UK-based stem cell therapy company, announces that all resolutions put to shareholders at today's Annual General Meeting were duly pa...
24/09/2015 - 06:29 StockMarketWire
ReNeuron Group said it has made great strides over the past year and it is now funded to deliver key clinical milestones ac...
|Dividend yield||0 %|
Equity Research (RENE)
ReNeuron Group plc
With significant financial resources able to support an extensive clinical development programme over the next three to four years, ReNeuron is well-positioned to determine the true value of its cell...
ReNeuron Group plc
ReNeuron presented two-year follow-up data from the PISCES study in disabled stroke patients, which confirm the potential for long-term benefits from treatment with its CTX neural stem cells....
ReNeuron Group plc
ReNeuron is facing a potentially transformational year in 2015, with key clinical data and relocation to a new cell manufacturing/research facility. Its allogeneic, CTX neural stem cell product is...
- 1 of 2
Latest discussion posts More
“I have copied this snippet straight off Reneuron's Web site. If they are meeting the program, watch this space! The primary endpoint of the study is safety, with patients ...”▼
“I'll stick it on my Christmas list as, after reading the extract, I want to find out what happens in the end. Interesting read, cheers. Si”▼
“book available from april 15 - hardcover costs #119 anyway chapter 8 is by K muir and J Sinden (available to buy chapter for ...”▼
Codes & Symbols
|Symbols||RENE, LSE:RENE, RENE.L, RENE:LN, LON:RENE, XLON:RENE|